Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

MedinCell S.A (PA: MEDCL)

 
MEDCL Technical Analysis
1.5
As on 9th Jun 2023 MEDCL STOCK Price closed @ 6.90 and we RECOMMEND Buy for LONG-TERM with Stoploss of 6.31 & Sell for SHORT-TERM with Stoploss of 8.13 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

MEDCLSTOCK Price

Open 6.96 Change Price %
High 7.17 1 Day 0.02 0.29
Low 6.90 1 Week 0.10 1.47
Close 6.90 1 Month -1.98 -22.30
Volume 87730 1 Year -3.10 -31.00
52 Week High 10.50 | 52 Week Low 4.77
 
PA France Most Active Stocks
FTI 5.91 -1.66%
VIEDS 0.72 4.35%
ALDRV 0.01 0.00%
AF 1.73 1.76%
CGG 0.69 -2.82%
ALVMG 0.50 0.00%
ACA 10.83 -0.91%
ALJXR 0.01 0.00%
CS 26.52 -2.00%
GLE 23.32 1.92%
 
PA France Top Gainers Stocks
ALAGP 5.50 13.40%
ALSEN 0.32 10.34%
MLPAP 0.55 10.00%
ALMAR 1.15 9.52%
CO 6.03 8.84%
CO 6.03 8.84%
CO 6.03 8.84%
ALGAU 1.92 8.47%
2MX 7.46 8.43%
ATA 0.13 8.33%
 
PA France Top Losers Stocks
AKOM 4.06 -37.05%
AKOM 4.06 -37.05%
FPN 0.02 -33.33%
MLWEL 0.23 -28.12%
ALPHA 0.08 -27.27%
ALPHA 0.08 -27.27%
MLCLP 4.48 -25.95%
ALHYG 0.05 -16.67%
ALLIX 10.80 -13.60%
MLERO 2.52 -12.50%
 
 
MEDCL
Daily Charts		 MEDCL
Intraday Charts		 Whats New @
Bazaartrend		 MEDCL
Free Analysis
 
MEDCL Important Levels Intraday
RESISTANCE7.42
RESISTANCE7.25
RESISTANCE7.15
RESISTANCE7.05
SUPPORT6.75
SUPPORT6.65
SUPPORT6.55
SUPPORT6.38
 
MEDCL Forecast May 2024
Share
4th UP Forecast11.2
3rd UP Forecast9.82
2nd UP Forecast8.97
1st UP Forecast8.12
1st DOWN Forecast5.68
2nd DOWN Forecast4.83
3rd DOWN Forecast3.98
4th DOWN Forecast2.6
 
MEDCL Weekly Forecast
4th UP Forecast8.96
3rd UP Forecast8.30
2nd UP Forecast7.89
1st UP Forecast7.48
1st DOWN Forecast6.32
2nd DOWN Forecast5.91
3rd DOWN Forecast5.50
4th DOWN Forecast4.84
 
MEDCL Forecast2024
4th UP Forecast18.48
3rd UP Forecast14.77
2nd UP Forecast12.47
1st UP Forecast10.18
1st DOWN Forecast3.62
2nd DOWN Forecast1.33
3rd DOWN Forecast-0.97
4th DOWN Forecast-4.68
 
 
MEDCL Other Details
Segment EQ
Market Capital 251922896.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
MEDCL Address
MEDCL
 
MEDCL Latest News
 
Your Comments and Response on MedinCell S.A
 
MEDCL Business Profile
MedinCell S.A. develops various therapeutic solutions. It develops solutions based on BEPO, a technology for long-acting injectable products based on proprietary copolymers and a biocompatible solvent, which solubilizes or suspends the active pharmaceutical ingredients. The company's products in development include mdc-IRM, a subcutaneous injection in Phase III trials for use in the treatment of schizophrenia; mdc-CWM, an intra-articular injection to treat pain and inflammation; and mdc-TJK, a subcutaneous injection in preclinical trials for use in the treatment of schizophrenia. Its product candidates in formulation research comprise subcutaneous injections, such as mdc-WWM for contraception; mdc-ANG for CNS related treatments; mdc-ELK for depression; and mdc-GRT for use in organ transplant, as well as perineural injections, including mdc-CMV for anesthesia and pain, and mdc-NVA for pain. The company is based in Jacou, France. Address: 3 rue des Frères Lumière, Jacou, France, 34830
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service